We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

75 hedge funds and large institutions have $300M invested in Editas Medicine in 2016 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 15

53% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 15

10% more funds holding

Funds holding: 68 → 75 (+7)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

45% less capital invested

Capital invested by funds: $550M → $300M (-$250M)

63% less call options, than puts

Call options by funds: $44K | Put options by funds: $120K

Holders
75
Holders Change
+7
Holders Change %
+10.29%
% of All Funds
2%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
24
Increased
23
Reduced
15
Closed
15
Calls
$44K
Puts
$120K
Net Calls
-$76K
Net Calls Change
-$76K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$14.7M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$9.43M
3
SM
Sabby Management
Florida
+$2.77M
4
Renaissance Technologies
Renaissance Technologies
New York
+$2.17M
5
BIT
BlackRock Institutional Trust
California
+$2.15M

Top Sellers

1
PVMCV
Polaris Venture Management Co VI
Massachusetts
-$10.2M
2
AI
Alphabet Inc
California
-$6.26M
3
Jennison Associates
Jennison Associates
New York
-$4.13M
4
EC
EcoR1 Capital
California
-$2.08M
5
Morgan Stanley
Morgan Stanley
New York
-$945K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$74M +$821K +40,051 +0.7%
PVMCV
2
Polaris Venture Management Co VI
Massachusetts
$56M -$10.2M -500,000 -11%
FP
3
Flagship Pioneering
Massachusetts
$46.6M +$70.8M +3,455,316 New
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$25.3M +$9.43M +460,280 +33%
DM
5
Deerfield Management
New York
$23M – – –
Viking Global Investors
6
Viking Global Investors
Connecticut
$23M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$16.8M +$14.7M +716,590 +134%
Capital World Investors
8
Capital World Investors
California
$3.98M – – –
Morgan Stanley
9
Morgan Stanley
New York
$3.4M -$945K -46,109 -15%
BFA
10
BlackRock Fund Advisors
California
$2.39M +$286K +13,944 +9%
BIT
11
BlackRock Institutional Trust
California
$2.3M +$2.15M +104,808 +159%
SM
12
Sabby Management
Florida
$1.82M +$2.77M +135,000 New
Renaissance Technologies
13
Renaissance Technologies
New York
$1.73M +$2.17M +106,096 +476%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.38M +$940K +45,875 +81%
State Street
15
State Street
Massachusetts
$1.38M +$50.3K +2,457 +2%
Northern Trust
16
Northern Trust
Illinois
$1.19M +$314K +15,328 +21%
CGL
17
Clarius Group LLC
Washington
$1.18M +$1.79M +87,231 New
Arrowstreet Capital
18
Arrowstreet Capital
Massachusetts
$1.17M +$1.77M +86,598 New
CC
19
Casdin Capital
New York
$1.15M +$1.75M +85,470 New
CS
20
Credit Suisse
Switzerland
$1.15M +$1.75M +85,332 New
OFM
21
Omega Fund Management
Massachusetts
$892K -$796K -38,846 -37%
Deutsche Bank
22
Deutsche Bank
Germany
$813K +$895K +43,680 +262%
Balyasny Asset Management
23
Balyasny Asset Management
Illinois
$809K +$1.23M +60,000 New
SOMRS
24
State of Michigan Retirement System
Michigan
$709K +$1.08M +52,573 New
WCM
25
Wildcat Capital Management
New York
$631K -$267K -13,025 -22%
1
2 3 4

EDIT Hedge Fund Activity: Q3 2016 in Review

75 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2016, worth a combined $300M — down 45% from $550M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new EDIT positions and 15 closed out — a net gain of 9 holders — while 23 added to existing stakes and 15 trimmed.

The largest buyer was Vanguard Group, adding an estimated $14.7M. The largest seller was Polaris Venture Management Co VI, cutting an estimated $10.2M.

  • 75 institutional investors held Editas Medicine (EDIT) as of Q3 2016, up from 68 in Q2 2016.
  • Funds reported $300M of Editas Medicine stock for Q3 2016, down 45% quarter-over-quarter.
  • 24 funds opened new Editas Medicine positions in Q3 2016 and 15 closed out, a net change of +9 holders.
  • The largest Editas Medicine buyer in Q3 2016 was Vanguard Group, an estimated $14.7M added.
  • The largest Editas Medicine seller in Q3 2016 was Polaris Venture Management Co VI, an estimated $10.2M sold.

Based on aggregated 13F filings for Q3 2016.